Illumina Inc

NASDAQ:ILMNUnited States

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.

Contact Information

Headquarters

5200 Illumina WaySAN DIEGO, CA, United States 92122-4616

Phone

858-202-4500

Fax

858-202-4766

Executives

Independent Non-Executive Chairman of the Board

Stephen Macmillan

Chief Executive Officer, Director

Jacob Thaysen

Chief Financial Officer

Ankur Dhingra

Chief People Officer

Aimee Hoyt

Senior Vice President, General Counsel, Company Secretary

Charles Dadswell